Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. (2021)
Attributed to:
Advanced glycosaminoglycan sequencing
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.15304
PubMed Identifier: 33125711
Publication URI: http://europepmc.org/abstract/MED/33125711
Type: Journal Article/Review
Volume: 178
Parent Publication: British journal of pharmacology
Issue: 3
ISSN: 0007-1188